-+ 0.00%
-+ 0.00%
-+ 0.00%

Mizuho Maintains Outperform on Axsome Therapeutics, Lowers Price Target to $306

Benzinga·07/31/2026 17:37:53
Listen to the news
Mizuho analyst Graig Suvannavejh maintains Axsome Therapeutics (NASDAQ:AXSM) with a Outperform and lowers the price target from $310 to $306.